Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04469530 |
Title | Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors (AflacST1903) |
Acronym | AflacST1903 |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Emory University |
Indications | |
Therapies | |
Age Groups: | child | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Aflac Cancer & Blood Disorders Centers | RECRUITING | Atlanta | Georgia | 30322 | United States | Details |
Children's Healthcare of Atlanta | RECRUITING | Atlanta | Georgia | 30322 | United States | Details |
Washington University School of Medicine | RECRUITING | Saint Louis | Missouri | 63110 | United States | Details |
Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center (UPMC) | RECRUITING | Pittsburgh | Pennsylvania | 15224 | United States | Details |
Texas Children's Cancer Center | RECRUITING | Houston | Texas | 77030 | United States | Details |